Nicholas Saraceno

With Peru's anchovy fishery opening its 2026 season with its lowest quota in a decade, Matts Johansen argues that aquaculture's growing appetite for omega-3s, not just El Niño, is what should actually be keeping supplement brands up at night.

A randomized, double-blind, placebo-controlled trial in reproductive-age women found that 8 weeks of standardized shatavari extract supplementation was associated with improvements in sexual function, vaginal moisture, fatigue, and sleep disturbance.

A new Walmart-exclusive supplement from Lemme joins a fast-growing, category of products marketed around the body's natural GLP-1 production.

BENEO's Denisse Colindres discusses how the fibermaxxing trend is evolving beyond "more fiber" to fiber diversity and layering, and what that shift means for formulation, claims, and category opportunity.

TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.

A randomized crossover trial finds that formulation, not just dose, determines how much of the hops-derived compound xanthohumol actually reaches the bloodstream.

A new gummy portfolio from ingredient and delivery-format supplier SIRIO Europe illustrates how quickly creatine is being repositioned for general wellness consumers.

This Q&A with Maypro's Lauren Clardy discusses the innovation areas—from scientific substantiation to delivery systems—set to define the future of skin and hair health.

In this teaser, Karin Linnewiel Hermoni discusses formulation traps for perimenopause products.

At The Outlook on Active Nutrition, Michelle Arent, RD, MPH, CSCS, CISSN, director of Olympic sports performance nutrition at the University of South Carolina, tells attendees that vague testing language is putting college athletes at risk, and called on supplement brands to build clearer, more transparent partnerships with universities and practitioners.

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.

The Indian branded-ingredient supplier has closed a growth investment from NDude Labs to expand clinical research and establish a dedicated US commercial operation, reflecting investor interest in ingredient companies that lead with published data.

A mixed cell-culture and mouse study found that Ahiflower oil, a plant-based omega-3 source, reduced markers of endothelial inflammation, blood lipids, and platelet clotting activity at levels comparable to fish oil.

At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.

CHAKHAN Co. has launched a black seed oil supplement in South Korea built on TriNutra's ThymoQuin ingredient, extending the branded ingredient's international footprint into a market where it has not previously been sold under a local retail brand.

CoreFX Ingredients is opening a European headquarters and research operation in County Cork, Ireland, partnering with a public agricultural research campus to work on formulation problems that have long limited how bioactive compounds perform in finished nutraceutical products.

Live from the Future Nutra Innovation Summit, Kerry Hughes, founder and president of Ethnopharm, explains why botanicals' complex compound networks represent nutrition's next innovation frontier.

Nammex is bringing its already-introduced ErinaPrime Lion's mane mycelium ingredient, standardized to a specific neuroactive compound, to SupplySide Global.

A laboratory study using human liver cells found that Optifolin+, a choline-enriched form of 5-methyltetrahydrofolate, increased methyl-donor metabolite levels, adding cell-based data to the folate ingredient's evidence base ahead of any human methylation research.

Paul Eftang used his FNIS session to walk through lab data on lion's mane and Tongkat Ali products that pass identity and DNA testing while containing few or none of the bioactive compounds their marketing claims are based on.

At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.

Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.

At the Future Nutra Innovation Summit, SPINS' Scott Dicker presented data showing protein and performance nutrition account for 45% of total supplement growth, while sleep, cognitive health, reproductive health, and weight loss formulas have flattened or declined.

Live from the Future Nutra Innovation Summit, Cassie Evans, PhD, RD, explains what sets Helaina's effera human-identical lactoferrin apart in multiple aspects.

The inaugural Future Nutra Innovation Summit opened with organizers pitching a networking-first alternative to the traditional trade show, followed by an NSF presentation on certification failure rates and consumer trust that set a tone for the rest of the event.

Ahead of her keynote at The Outlook on Active Nutrition, Michelle Arent, USC's Olympic sports performance nutrition director, shares her rigorous supplement vetting process, industry gaps in usability, and a preview of her presentation.

In the eighth episode, Nicholas Saraceno examines how social media has reshaped where people get their health and supplement information, from AI-generated "wellness experts" running fabricated ads to registered dietitians and physicians building their own followings to counter it.

dsm-firmenich is directing formulators toward taste and flavor-masking technology earlier in medical nutrition product development, citing survey data on why patients stop taking oral nutritional supplements.

A 28-day evaluation of TriNutra’s 5% B'utyQuin scalp lotion reported reduced hair loss and modest density increases in 22 adults, adding early clinical data to a cosmetic ingredient formulators are positioning for scalp health claims.